Invention Grant
- Patent Title: Sublingual epinephrine tablets
-
Application No.: US17575489Application Date: 2022-01-13
-
Publication No.: US12042472B2Publication Date: 2024-07-23
- Inventor: G. Lynn Howard , Nicholas J. Farina , Edward J. Walters , Christopher Howard
- Applicant: pHase Pharmaceuticals LLC
- Applicant Address: US TX Dallas
- Assignee: pHase Pharmaceuticals LLC
- Current Assignee: pHase Pharmaceuticals LLC
- Current Assignee Address: US TX Dallas
- The original application number of the division: US16114939 2018.08.28
- Main IPC: A61K31/137
- IPC: A61K31/137 ; A61K9/00 ; A61K9/20 ; A61K47/12 ; A61K47/26 ; A61K47/38 ; A61P3/08 ; A61P37/08
Abstract:
The present disclosure provides sublingual epinephrine tablets and methods of treating anaphylaxis, methods for concomitant therapy during a cardiac event, treating hypoglycemia, and prophylaxis for immunotherapy, using sublingual epinephrine tablets.
Public/Granted literature
- US20220133654A1 SUBLINGUAL EPINEPHRINE TABLETS Public/Granted day:2022-05-05
Information query
